Improved Mortality Associated with ACE-I and Beta Blocker Therapy in Heart Failure with Preserved Ejection Fraction: An Analysis of the Biomarkers in Acute Heart Failure (BACH) Trial

被引：0

作者：

Parekh, Niraj V. ^{[1
]}

Singh, Kabir ^{[1
]}

Clopton, Paul ^{[2
]}

Anand, Inder ^{[3
]}

Christenson, Robert ^{[4
]}

Daniels, Lori B. ^{[1
]}

Hogan, Christopher ^{[5
]}

Neath, Sean-Xavier ^{[1
]}

Nowak, Richard ^{[6
]}

Peacock, W. Franklin ^{[7
]}

Wu, Alan ^{[8
]}

Anker, Stefan D. ^{[9
]}

Maisel, Alan S. ^{[1
,2
]}

机构：

[1] UCSD, San Diego, CA USA

[2] Vet Affairs, San Diego, CA USA

[3] Vet Affairs, Minneapolis, MN USA

[4] Univ Maryland, Baltimore, MD 21201 USA

[5] Virginia Commonwealth Univ, Richmond, VA USA

[6] Henry Ford Hlth Syst, Detroit, MI USA

[7] Cleveland Clin, Cleveland, OH 44106 USA

[8] San Francisco Gen Hosp, San Francisco, CA 94110 USA

[9] Charite, D-13353 Berlin, Germany

来源：

JOURNAL OF CARDIAC FAILURE | 2009年 / 15卷 / 06期

关键词：

D O I：

10.1016/j.cardfail.2009.06.130

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

345

引用

页码：S104 / S104

页数：1

共 50 条

[31] MEDICAL THERAPY FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION
Kjeldsen, Sverre Erik
JOURNAL OF HYPERTENSION, 2023, 41 : E69 - E69
[32] Cell Therapy in Heart Failure with Preserved Ejection Fraction
Frljak, Sabina
Poglajen, Gregor
Vrtovec, Bojan
CARDIAC FAILURE REVIEW, 2022, 8
[33] Device Therapy for Heart Failure with Preserved Ejection Fraction
Salah, Husam M.
Levin, Allison P.
Fudim, Marat
CARDIOLOGY CLINICS, 2022, 40 (04) : 507 - 515
[34] Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction
Peters, Anthony E.
DeVore, Adam D.
CARDIOLOGY CLINICS, 2022, 40 (04) : 473 - 489
[35] Candidate biomarkers in heart failure with reduced and preserved ejection fraction
Sinning, Christoph
Zengin, Elvin
Zeller, Tanja
Schnabel, Renate B.
Blankenberg, Stefan
Westermann, Dirk
BIOMARKERS, 2015, 20 (04) : 258 - 265
[36] Circulating biomarkers in patients with heart failure and preserved ejection fraction
O'Meara E.
De Denus S.
Rouleau J.-L.
Desai A.
Current Heart Failure Reports, 2013, 10 (4) : 350 - 358
[37] Biomarkers in Heart Failure with Preserved Ejection Fraction: Problems and Opportunities
Triposkiadis, Filippos K.
CARDIOLOGY, 2017, 136 (04) : 228 - 229
[38] Heart Failure With Reduced Ejection Fraction Is Associated With Higher In Hospital Mortality Than Heart Failure With Preserved Ejection Fraction: A National Retrospective Cohort
Francis-Morel, Garry
JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 283 - 283
[39] Curative effect analysis of urapidil on heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
Yuan, Xiao-Ye
Ding, Cun-Tao
Li, Jing
Tan, Jing
Wang, Yan-Ling
Fan, Zhen-Xing
He, Jing-Yu
Yang, Wei
Hua, Qi
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 494 - 503
[40] Heart Rate and Heart Failure With Preserved Ejection Fraction Time to Slow β-Blocker Use?
Meyer, Markus
LeWinter, Martin M.
CIRCULATION-HEART FAILURE, 2019, 12 (08)

← 1 2 3 4 5 →